应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02126 药明巨诺-B
已收盘 07-22 16:08:56
1.800
+0.060
+3.45%
最高
1.800
最低
1.740
成交量
15.55万
今开
1.740
昨收
1.740
日振幅
3.45%
总市值
7.47亿
流通市值
7.47亿
总股本
4.15亿
成交额
27.32万
换手率
0.04%
流通股本
4.15亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
药明巨诺-B盘中异动 股价大跌6.10%
自选股智能写手 · 07-19
药明巨诺-B盘中异动 股价大跌6.10%
药明巨诺-B(02126)股价上升5.556%,现价港币$1.9
阿斯达克财经 · 07-11
药明巨诺-B(02126)股价上升5.556%,现价港币$1.9
药明巨诺-B盘中异动 早盘股价大涨5.00%报1.890港元
自选股智能写手 · 07-11
药明巨诺-B盘中异动 早盘股价大涨5.00%报1.890港元
东曜药业-B盘中异动 大幅上涨7.98%报2.030港元
自选股智能写手 · 07-03
东曜药业-B盘中异动 大幅上涨7.98%报2.030港元
药明巨诺-B盘中异动 早盘股价大涨6.35%
自选股智能写手 · 07-03
药明巨诺-B盘中异动 早盘股价大涨6.35%
药明巨诺-B盘中异动 大幅下跌5.05%报1.861港元
自选股智能写手 · 07-02
药明巨诺-B盘中异动 大幅下跌5.05%报1.861港元
药明巨诺-B(02126)股价下跌5.473%,现价港币$1.9
阿斯达克财经 · 06-27
药明巨诺-B(02126)股价下跌5.473%,现价港币$1.9
药明巨诺-B盘中异动 临近收盘大幅下跌5.36%报1.960港元
自选股智能写手 · 06-24
药明巨诺-B盘中异动 临近收盘大幅下跌5.36%报1.960港元
药明巨诺-B(02126)股价下跌5.314%,现价港币$1.96
阿斯达克财经 · 06-24
药明巨诺-B(02126)股价下跌5.314%,现价港币$1.96
药明巨诺-B盘中异动 早盘快速下挫5.21%报2.001港元
自选股智能写手 · 06-20
药明巨诺-B盘中异动 早盘快速下挫5.21%报2.001港元
药明巨诺-B(02126)股价下跌5.213%,现价港币$2.0
阿斯达克财经 · 06-20
药明巨诺-B(02126)股价下跌5.213%,现价港币$2.0
药明巨诺-B盘中异动 急速上涨8.25%
自选股智能写手 · 06-13
药明巨诺-B盘中异动 急速上涨8.25%
首单CAR–T商业化产品出境正推进,浦东综改助推行业出海
财通社 · 06-11
首单CAR–T商业化产品出境正推进,浦东综改助推行业出海
药明巨诺-B(02126)股价下跌5.172%,现价港币$2.2
阿斯达克财经 · 06-07
药明巨诺-B(02126)股价下跌5.172%,现价港币$2.2
药明巨诺-B盘中异动 股价大跌5.15%
自选股智能写手 · 06-03
药明巨诺-B盘中异动 股价大跌5.15%
港股异动 | 药明巨诺-B(02126)涨超8% SLE临床数据呈良好安全性
智通财经 · 05-31
港股异动 | 药明巨诺-B(02126)涨超8% SLE临床数据呈良好安全性
药明巨诺-B(02126)上涨7.83%,报2.34元/股
金融界 · 05-31
药明巨诺-B(02126)上涨7.83%,报2.34元/股
药明巨诺-B股价上涨10.59% 市值涨8076.45万港元
自选股智能写手 · 05-31
药明巨诺-B股价上涨10.59% 市值涨8076.45万港元
药明巨诺(02126.HK)瑞基奥仑赛注射液初步临床数据显示安全性良好
阿斯达克财经 · 05-30
药明巨诺(02126.HK)瑞基奥仑赛注射液初步临床数据显示安全性良好
药明巨诺-B(02126)在EULAR 2024公布瑞基奥仑赛注射液用于治疗活动性系统性红斑狼疮中国成人患者中的初步临床数据
智通财经网 · 05-30
药明巨诺-B(02126)在EULAR 2024公布瑞基奥仑赛注射液用于治疗活动性系统性红斑狼疮中国成人患者中的初步临床数据
加载更多
公司概况
公司名称:
药明巨诺-B
所属市场:
SEHK
上市日期:
--
主营业务:
药明巨诺(开曼)有限公司是一家主要从事临床及临床前阶段细胞治疗的中国公司。该公司致力于为中国市场开发细胞治疗手段,为中国癌症患者带来新兴治疗方式。通过其子公司,其建立了一个专注为血液癌症及实体瘤开发、制造和商业化突破性细胞免疫疗法的一体化平台。其主打候选产品relmacabtagene autoleucel(relma-cel)是针对复发或难治(r/r)B细胞淋巴瘤的自体抗CD19 CAR-T疗法。该公司主要于中国市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02126","market":"HK","secType":"STK","nameCN":"药明巨诺-B","latestPrice":1.8,"timestamp":1721635736027,"preClose":1.74,"halted":0,"volume":155500,"delay":0,"floatShares":415067188,"shares":415067188,"eps":-1.9985299,"marketStatus":"已收盘","marketStatusCode":5,"change":0.06,"latestTime":"07-22 16:08:56","open":1.74,"high":1.8,"low":1.74,"amount":273240,"amplitude":0.034483,"askPrice":1.8,"askSize":112500,"bidPrice":1.75,"bidSize":10000,"shortable":0,"etf":0,"ttmEps":-1.998529864830257,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1604332800000,"adjPreClose":1.74,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":0.493025,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02126","defaultTab":"news","newsList":[{"id":"2452487684","title":"药明巨诺-B盘中异动 股价大跌6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452487684","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452487684?lang=zh_cn&edition=full","pubTime":"2024-07-19 15:23","pubTimestamp":1721373780,"startTime":"0","endTime":"0","summary":"2024年07月19日下午盘15时23分,药明巨诺-B股票出现波动,股价急速下跌6.10%。截至发稿,该股报1.710港元/股,成交量42.65万股,换手率0.10%,振幅6.04%。药明巨诺-B股票所在的生物技术行业中,整体跌幅为0.55%。药明巨诺-B公司简介:药明巨诺(开曼)有限公司是一家主要从事临床及临床前阶段细胞治疗的中国公司。该公司致力于为中国市场开发细胞治疗手段,为中国癌症患者带来新兴治疗方式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719152300aefa7630&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719152300aefa7630&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2450887265","title":"药明巨诺-B(02126)股价上升5.556%,现价港币$1.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2450887265","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450887265?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:50","pubTimestamp":1720662600,"startTime":"0","endTime":"0","summary":"[上升股]药明巨诺-B(02126) 股价在上午09:50比前收市价上升5.556%,现股价为港币$1.9。至目前为止,今日最高价为$1.9,而最低价为$1.85。总成交量为3000股,总成交金额为港币$5675。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2407111329/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1574","02126","BK1583"],"gpt_icon":0},{"id":"2450744198","title":"药明巨诺-B盘中异动 早盘股价大涨5.00%报1.890港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450744198","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450744198?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:36","pubTimestamp":1720661784,"startTime":"0","endTime":"0","summary":"2024年07月11日早盘09时36分,药明巨诺-B股票出现波动,股价急速拉升5.00%。截至发稿,该股报1.890港元/股,成交量500股,换手率0.00%,振幅0.00%。药明巨诺-B股票所在的生物技术行业中,整体涨幅为0.32%。该公司致力于为中国市场开发细胞治疗手段,为中国癌症患者带来新兴治疗方式。该公司主要于中国市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711093624af91b655&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711093624af91b655&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","BK1574","02126"],"gpt_icon":0},{"id":"2448149763","title":"东曜药业-B盘中异动 大幅上涨7.98%报2.030港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448149763","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448149763?lang=zh_cn&edition=full","pubTime":"2024-07-03 10:57","pubTimestamp":1719975443,"startTime":"0","endTime":"0","summary":"2024年07月03日早盘10时57分,东曜药业-B股票出现波动,股价快速拉升7.98%。截至发稿,该股报2.030港元/股,成交量3200股,换手率0.00%,振幅6.91%。东曜药业-B股票所在的生物技术行业中,整体跌幅为0.16%。其相关个股中,方达控股、绿竹生物-B、云顶新耀-B涨幅较大,振幅较大的相关个股有药明巨诺-B、盛禾生物-B、乐普生物-B,振幅分别为17.46%、15.10%、7.85%。东曜药业-B公司简介:东曜药业股份有限公司是一家主要从事开发及商业化肿瘤药物及疗法的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703105723968190c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703105723968190c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1583","01875","02898","BK1574","BK1161"],"gpt_icon":0},{"id":"2448749110","title":"药明巨诺-B盘中异动 早盘股价大涨6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448749110","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448749110?lang=zh_cn&edition=full","pubTime":"2024-07-03 09:39","pubTimestamp":1719970799,"startTime":"0","endTime":"0","summary":"2024年07月03日早盘09时39分,药明巨诺-B股票出现异动,股价快速上涨6.35%。药明巨诺-B股票所在的生物技术行业中,整体涨幅为0.01%。其相关个股中,药明巨诺-B、盛禾生物-B、方达控股涨幅较大,振幅较大的相关个股有科伦博泰生物-B、盛禾生物-B、基石药业-B,振幅分别为7.78%、7.17%、6.14%。药明巨诺-B公司简介:药明巨诺(开曼)有限公司是一家主要从事临床及临床前阶段细胞治疗的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703093959af90467f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703093959af90467f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1161","02126"],"gpt_icon":0},{"id":"2448427979","title":"药明巨诺-B盘中异动 大幅下跌5.05%报1.861港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448427979","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448427979?lang=zh_cn&edition=full","pubTime":"2024-07-02 09:31","pubTimestamp":1719883891,"startTime":"0","endTime":"0","summary":"2024年07月02日早盘09时31分,药明巨诺-B股票出现异动,股价大幅下跌5.05%。截至发稿,该股报1.861港元/股,成交量500股,换手率0.00%,振幅0.00%。药明巨诺-B股票所在的生物技术行业中,整体涨幅为0.57%。药明巨诺-B公司简介:药明巨诺(开曼)有限公司是一家主要从事临床及临床前阶段细胞治疗的中国公司。该公司致力于为中国市场开发细胞治疗手段,为中国癌症患者带来新兴治疗方式。该公司主要于中国市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702093131af9012e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702093131af9012e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1161","BK1574","BK1583"],"gpt_icon":0},{"id":"2446305976","title":"药明巨诺-B(02126)股价下跌5.473%,现价港币$1.9","url":"https://stock-news.laohu8.com/highlight/detail?id=2446305976","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446305976?lang=zh_cn&edition=full","pubTime":"2024-06-27 14:16","pubTimestamp":1719468960,"startTime":"0","endTime":"0","summary":"[下跌股]药明巨诺-B(02126) 股价在下午02:16比前收市价下跌5.473%,现股价为港币$1.9。至目前为止,今日最高价为$2.02,而最低价为$1.9。总成交量为10.25万股,总成交金额为港币$20.241万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2406273653/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1161","02126","BK1583"],"gpt_icon":0},{"id":"2445428280","title":"药明巨诺-B盘中异动 临近收盘大幅下跌5.36%报1.960港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445428280","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445428280?lang=zh_cn&edition=full","pubTime":"2024-06-24 15:59","pubTimestamp":1719215990,"startTime":"0","endTime":"0","summary":"2024年06月24日临近收盘15时59分,药明巨诺-B股票出现波动,股价大幅下跌5.36%。截至发稿,该股报1.960港元/股,成交量12.9万股,换手率0.03%,振幅3.86%。药明巨诺-B股票所在的生物技术行业中,整体涨幅为0.12%。药明巨诺-B公司简介:药明巨诺(开曼)有限公司是一家主要从事临床及临床前阶段细胞治疗的中国公司。该公司致力于为中国市场开发细胞治疗手段,为中国癌症患者带来新兴治疗方式。该公司主要于中国市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062415595096816381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062415595096816381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02126","BK1161","BK1583"],"gpt_icon":0},{"id":"2445423590","title":"药明巨诺-B(02126)股价下跌5.314%,现价港币$1.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2445423590","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445423590?lang=zh_cn&edition=full","pubTime":"2024-06-24 15:59","pubTimestamp":1719215940,"startTime":"0","endTime":"0","summary":"[下跌股]药明巨诺-B(02126) 股价在下午03:59比前收市价下跌5.314%,现股价为港币$1.96。至目前为止,今日最高价为$2.04,而最低价为$1.96。总成交量为12.9万股,总成交金额为港币$25.616万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2406242463/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02126","BK1583","BK1574"],"gpt_icon":0},{"id":"2444323230","title":"药明巨诺-B盘中异动 早盘快速下挫5.21%报2.001港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444323230","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444323230?lang=zh_cn&edition=full","pubTime":"2024-06-20 10:25","pubTimestamp":1718850307,"startTime":"0","endTime":"0","summary":"2024年06月20日早盘10时25分,药明巨诺-B股票出现波动,股价大幅下挫5.21%。截至发稿,该股报2.001港元/股,成交量15.25万股,换手率0.04%,振幅9.48%。其相关个股中,帝王国际投资、中国抗体-B、荣昌生物涨幅较大,振幅较大的相关个股有中国抗体-B、药明巨诺-B、来凯医药-B,振幅分别为10.90%、9.48%、6.69%。该公司致力于为中国市场开发细胞治疗手段,为中国癌症患者带来新兴治疗方式。该公司主要于中国市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620102507af8e58b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620102507af8e58b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2444232679","title":"药明巨诺-B(02126)股价下跌5.213%,现价港币$2.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2444232679","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444232679?lang=zh_cn&edition=full","pubTime":"2024-06-20 10:25","pubTimestamp":1718850300,"startTime":"0","endTime":"0","summary":"[下跌股]药明巨诺-B(02126) 股价在上午10:25比前收市价下跌5.213%,现股价为港币$2.0。至目前为止,今日最高价为$2.2,而最低价为$2.0。总成交量为12.85万股,总成交金额为港币$26.364万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240620434/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1161","02126","BK1574"],"gpt_icon":0},{"id":"2443354303","title":"药明巨诺-B盘中异动 急速上涨8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443354303","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443354303?lang=zh_cn&edition=full","pubTime":"2024-06-13 09:33","pubTimestamp":1718242392,"startTime":"0","endTime":"0","summary":"2024年06月13日早盘09时33分,药明巨诺-B股票出现异动,股价急速上涨8.25%。药明巨诺-B股票所在的生物技术行业中,整体涨幅为1.39%。药明巨诺-B公司简介:药明巨诺(开曼)有限公司是一家主要从事临床及临床前阶段细胞治疗的中国公司。该公司致力于为中国市场开发细胞治疗手段,为中国癌症患者带来新兴治疗方式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613093312aef4b2aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613093312aef4b2aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2442794360","title":"首单CAR–T商业化产品出境正推进,浦东综改助推行业出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2442794360","media":"财通社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442794360?lang=zh_cn&edition=full","pubTime":"2024-06-11 20:04","pubTimestamp":1718107440,"startTime":"0","endTime":"0","summary":"据第一财经,一项名为“CAR–T细胞治疗商业化产品出境管理”的制度创新,正在为浦东新区乃至上海和全国的CAR–T细胞治疗行业拓展海外市场,带来可观的想象空间。6月11日举行的“潮涌浦江”系列活动引领区改革创新暨浦东新区综合改革试点成果发布会上,药明巨诺高级副总裁杨苏表示,目前进出境的跨部门联合审批通道已全部走通,企业正积极推动商业化运营早日实现突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061120050895a4bfc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061120050895a4bfc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","02126","BK1574"],"gpt_icon":0},{"id":"2441080084","title":"药明巨诺-B(02126)股价下跌5.172%,现价港币$2.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2441080084","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441080084?lang=zh_cn&edition=full","pubTime":"2024-06-07 14:59","pubTimestamp":1717743540,"startTime":"0","endTime":"0","summary":"[下跌股]药明巨诺-B(02126) 股价在下午02:59比前收市价下跌5.172%,现股价为港币$2.2。至目前为止,今日最高价为$2.36,而最低价为$2.2。总成交量为3.25万股,总成交金额为港币$7.468万。","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2406071558/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1161","02126","BK1574"],"gpt_icon":0},{"id":"2440843494","title":"药明巨诺-B盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440843494","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440843494?lang=zh_cn&edition=full","pubTime":"2024-06-03 10:42","pubTimestamp":1717382528,"startTime":"0","endTime":"0","summary":"2024年06月03日早盘10时42分,药明巨诺-B股票出现波动,股价急速下跌5.15%。截至发稿,该股报2.211港元/股,成交量16.75万股,换手率0.04%,振幅6.01%。药明巨诺-B股票所在的生物技术行业中,整体跌幅为0.07%。药明巨诺-B公司简介:药明巨诺(开曼)有限公司是一家主要从事临床及临床前阶段细胞治疗的中国公司。该公司致力于为中国市场开发细胞治疗手段,为中国癌症患者带来新兴治疗方式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603104208941ebbe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603104208941ebbe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","02126","BK1574"],"gpt_icon":0},{"id":"2439931073","title":"港股异动 | 药明巨诺-B(02126)涨超8% SLE临床数据呈良好安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=2439931073","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439931073?lang=zh_cn&edition=full","pubTime":"2024-05-31 14:34","pubTimestamp":1717137248,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,药明巨诺-B(02126)涨超8%,截至发稿,涨8.29%,报2.35港元,成交额204.18万港元。消息面上,药明巨诺发布公告称,该公司在2024欧洲风湿病学大会(EULAR 2024)上公布了瑞基奥仑赛注射液在中国成人活动性系统性红斑狼疮(SLE)患者中的最新临床数据。研究的初步资料表明,瑞基奥仑赛注射液能够使中重度红斑狼疮患者达到深度且持久的疾病缓解,且安全性良好。中金此前指出,中重度SLE存在较高的治疗需求,公司CAR-T产品全球率先扩展至SLE慢性病领域,有望在自免领域革新患者治疗方式,进而拓展CAR-T 疗法的市场空间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1128915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02126","HSCEI","07226","BK1161","SLE","HSTECH","YANG","BK4077","BK1574","BK1583"],"gpt_icon":0},{"id":"2439806829","title":"药明巨诺-B(02126)上涨7.83%,报2.34元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2439806829","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439806829?lang=zh_cn&edition=full","pubTime":"2024-05-31 09:52","pubTimestamp":1717120342,"startTime":"0","endTime":"0","summary":"5月31日,药明巨诺-B(02126)盘中上涨7.83%,截至09:52,报2.34元/股,成交100.43万元。药明巨诺(开曼)有限公司是一家专注于开发、生产和商业化细胞免疫治疗产品的生物科技公司。该公司已建立了国际顶尖的细胞免疫疗法的技术与产品开发平台,并拥有涵盖血液和实体肿瘤的高潜力产品管线。截至2023年年报,药明巨诺-B营业总收入1.74亿元、净利润-7.68亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/31095240843417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02126","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2439845189","title":"药明巨诺-B股价上涨10.59% 市值涨8076.45万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439845189","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439845189?lang=zh_cn&edition=full","pubTime":"2024-05-31 09:30","pubTimestamp":1717119005,"startTime":"0","endTime":"0","summary":"2024年05月31日早盘09时30分,药明巨诺-B股票出现波动,股价大幅拉升10.59%。截至发稿,该股报2.401港元/股,成交量8.1万股,换手率0.02%,振幅3.23%。药明巨诺-B股票所在的生物技术行业中,整体涨幅为1.27%。其相关个股中,康方生物、药明巨诺-B、康宁杰瑞制药-B涨幅较大,振幅较大的相关个股有康方生物、科笛-B、药明巨诺-B,振幅分别为47.50%、3.71%、3.23%。该公司主要于中国市场开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531093005af8b4111&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531093005af8b4111&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02126","BK1583"],"gpt_icon":0},{"id":"2439697840","title":"药明巨诺(02126.HK)瑞基奥仑赛注射液初步临床数据显示安全性良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2439697840","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439697840?lang=zh_cn&edition=full","pubTime":"2024-05-30 16:46","pubTimestamp":1717058760,"startTime":"0","endTime":"0","summary":"药明巨诺-B(02126.HK) 公布,在2024欧洲风湿病学大会(EULAR 2024)上公布瑞基奥仑赛注射液在中国成人活动性系统性红斑狼疮(SLE)患者中的最新临床数据。当中,所有剂量组的患者均呈现良好的安全性和耐受性,仅出现1例3级细胞因数释放综合症(CRS),没有出现3级及以上神经毒性,仅2例患者出现3级感染,所有不良事件均能在经过相应治疗后恢复。初步资料表明,瑞基奥仑赛注射液能够使中重度红斑狼疮患者达到深度且持久的疾病缓解,且安全性良好。(jl/cy)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20210524130515392_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20210524130515392_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1353232/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1583","02126","BK1161"],"gpt_icon":0},{"id":"2439969287","title":"药明巨诺-B(02126)在EULAR 2024公布瑞基奥仑赛注射液用于治疗活动性系统性红斑狼疮中国成人患者中的初步临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2439969287","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439969287?lang=zh_cn&edition=full","pubTime":"2024-05-30 16:39","pubTimestamp":1717058389,"startTime":"0","endTime":"0","summary":"智通财经APP讯,药明巨诺-B 发布公告,该公司在2024欧洲风湿病学大会上公布了瑞基奥仑赛注射液在中国成人活动性系统性红斑狼疮患者中的最新临床数据。尤其是需要大剂量激素及免疫抑制剂进行治疗的中重度活动性SLE患者。此外,瑞基奥仑赛展示出良好的安全性。该IIT研究的初步资料表明,瑞基奥仑赛注射液能够使中重度红斑狼疮患者达到深度且持久的疾病缓解,且安全性良好。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405301642049f045f65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405301642049f045f65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1161","02126"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0543},{"period":"1month","weight":-0.1754},{"period":"3month","weight":0.0116},{"period":"6month","weight":-0.1256},{"period":"1year","weight":-0.315},{"period":"ytd","weight":-0.2301}],"compareEarnings":[{"period":"1week","weight":-0.0479},{"period":"1month","weight":-0.0549},{"period":"3month","weight":0.0736},{"period":"6month","weight":0.1378},{"period":"1year","weight":-0.0798},{"period":"ytd","weight":0.0217}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明巨诺(开曼)有限公司是一家主要从事临床及临床前阶段细胞治疗的中国公司。该公司致力于为中国市场开发细胞治疗手段,为中国癌症患者带来新兴治疗方式。通过其子公司,其建立了一个专注为血液癌症及实体瘤开发、制造和商业化突破性细胞免疫疗法的一体化平台。其主打候选产品relmacabtagene autoleucel(relma-cel)是针对复发或难治(r/r)B细胞淋巴瘤的自体抗CD19 CAR-T疗法。该公司主要于中国市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.01079},{"month":2,"riseRate":0.75,"avgChangeRate":0.067143},{"month":3,"riseRate":0,"avgChangeRate":-0.17939},{"month":4,"riseRate":0.25,"avgChangeRate":-0.041215},{"month":5,"riseRate":0.5,"avgChangeRate":0.022518},{"month":6,"riseRate":0.25,"avgChangeRate":-0.080401},{"month":7,"riseRate":0.25,"avgChangeRate":-0.093277},{"month":8,"riseRate":0,"avgChangeRate":-0.157105},{"month":9,"riseRate":0,"avgChangeRate":-0.221444},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.041718},{"month":11,"riseRate":0.666667,"avgChangeRate":0.315863},{"month":12,"riseRate":0.75,"avgChangeRate":-0.039996}],"exchange":"SEHK","name":"药明巨诺-B","nameEN":"JW THERAP-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明巨诺-B(02126)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明巨诺-B(02126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明巨诺-B,02126,药明巨诺-B股票,药明巨诺-B股票老虎,药明巨诺-B股票老虎国际,药明巨诺-B行情,药明巨诺-B股票行情,药明巨诺-B股价,药明巨诺-B股市,药明巨诺-B股票价格,药明巨诺-B股票交易,药明巨诺-B股票购买,药明巨诺-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明巨诺-B(02126)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明巨诺-B(02126)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}